Aspira Women’s Health (NYSE:AWH) Research Coverage Started at

Investment analysts at began coverage on shares of Aspira Women’s Health (NYSE:AWHGet Rating) in a report released on Sunday. The brokerage set a “sell” rating on the stock.

Aspira Women’s Health Stock Performance

Shares of NYSE:AWH opened at $0.40 on Friday. Aspira Women’s Health has a 1 year low of $0.29 and a 1 year high of $1.26. The stock has a market cap of $49.84 million, a P/E ratio of -1.48 and a beta of 2.96. The firm’s 50-day simple moving average is $0.47.

About Aspira Women’s Health

(Get Rating)

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Featured Articles

Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with's FREE daily email newsletter.